Mammary Analogue Secretory Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
17
|
|
0.100 |
None |
0.967 |
30 |
|
2012 |
2019 |
Infantile fibrosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
17
|
|
0.100 |
None |
1.000 |
20 |
|
1998 |
2019 |
Mesoblastic Nephroma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
17
|
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2016 |
Trisomy 11
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
17
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Somatotrophinoma, Familial
|
disease |
Neoplasms; Nervous System Diseases; Endocrine System Diseases
|
Neoplastic Process
|
18
|
|
0.040 |
None |
1.000 |
4 |
|
2001 |
2019 |
Secretory breast carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
19
|
|
0.100 |
None |
0.962 |
26 |
|
2002 |
2020 |
Myofibromatosis
|
disease |
Neoplasms
|
Neoplastic Process
|
19
|
7
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Congenital thrombocytopenia
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
19
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hypereosinophilic syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
19
|
2
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Polymorphous low grade adenocarcinoma
|
disease |
|
Neoplastic Process
|
23
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Infant Leukemia
|
disease |
|
Neoplastic Process
|
27
|
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2009 |
Histiocytoma, Angiomatoid Fibrous
|
disease |
Neoplasms
|
Neoplastic Process
|
28
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hyperdiploid B Acute Lymphoblastic Leukemia
|
disease |
|
Neoplastic Process
|
32
|
13
|
0.030 |
None |
1.000 |
3 |
|
2010 |
2019 |
Chronic leukemia (category)
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
32
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Acute myeloid leukemia, minimal differentiation
|
disease |
Neoplasms
|
Neoplastic Process
|
33
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2012 |
Dermatofibrosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Recurrent Childhood Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
37
|
|
0.020 |
None |
0.500 |
2 |
|
1998 |
2001 |
Adult Acute Megakaryoblastic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
38
|
4
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hypereosinophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
39
|
4
|
0.020 |
None |
1.000 |
2 |
|
2006 |
2012 |
Isodicentric Chromosome 15 Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
39
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Congenital Mesoblastic Nephroma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
42
|
5
|
0.400 |
None |
1.000 |
11 |
|
1998 |
2019 |
Chronic eosinophilic leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
42
|
9
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Common acute lymphoblastic leukemia
|
disease |
|
Neoplastic Process
|
43
|
|
0.030 |
None |
1.000 |
3 |
|
1998 |
2010 |
Idiopathic Hypereosinophilic Syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
43
|
5
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2005 |
Adult Pre-B Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
44
|
2
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2011 |